Silvant Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,607	Closed	-$560K	–	316
2025 Q3	$560K	Buy	+18,607	New	+$558K	0.02%	162
2022 Q4	–	Sell	-3,362	Closed	-$139K	–	346
2022 Q3	$139K	Hold	3,362	–	–	0.01%	223
2022 Q2	$201K	Hold	3,362	–	–	0.05%	152
2022 Q1	$244K	Hold	3,362	–	–	0.05%	156
2021 Q4	$283K	Sell	3,362 -216	-6%	-$17.6K	0.05%	156
2021 Q3	$323K	Hold	3,578	–	–	0.06%	148
2021 Q2	$341K	Hold	3,578	–	–	0.05%	147
2021 Q1	$407K	Hold	3,578	–	–	0.07%	135
2020 Q4	$495K	Hold	3,578	–	–	0.08%	124
2020 Q3	$294K	Sell	3,578 -992	-22%	-$82.2K	0.06%	149
2020 Q2	$357K	Hold	4,570	–	–	0.06%	130
2020 Q1	$203K	Hold	4,570	–	–	0.04%	152
2019 Q4	$195K	Hold	4,570	–	–	0.04%	183
2019 Q3	$196K	Hold	4,570	–	–	0.04%	175
2019 Q2	$290K	Hold	4,570	–	–	0.05%	161
2019 Q1	$317K	Hold	4,570	–	–	0.06%	149
2018 Q4	$199K	Hold	4,570	–	–	0.04%	177
2018 Q3	$349K	Hold	4,570	–	–	0.04%	150
2018 Q2	$351K	Hold	4,570	–	–	0.04%	147
2018 Q1	$233K	Buy	+4,570	New	+$230K	0.03%	187